Controlling and monitoring buprenorphine dosing does not benefit treatment engagement and adherence during the post-detoxification period - A pilot randomized controlled trial
Publication date: December 2026 Source: Drug and Alcohol Dependence Reports, Volume 21 Author(s): Zev Schuman-Olivier, Grace Janzow, Michael William Flores, Amanda Sharp, Cassandra Harding, Khary K. Rigg, Holly Hills, Kathleen A. Moore
Controlling and monitoring buprenorphine dosing does not benefit treatment engagement and adherence during the post-detoxification period - A pilot randomized controlled trial. // Drug and Alcohol Dependence Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2772724626000806?dgcid=rss_sd_all
Controlling and monitoring buprenorphine dosing does not benefit treatment engagement and adherence during the post-detoxification period - A pilot randomized controlled trial. Drug and Alcohol Dependence Reports. https://www.sciencedirect.com/science/article/pii/S2772724626000806?dgcid=rss_sd_all
“Controlling and monitoring buprenorphine dosing does not benefit treatment engagement and adherence during the post-detoxification period - A pilot randomized controlled trial.” Drug and Alcohol Dependence Reports.
@article{article43365,
title = {Controlling and monitoring buprenorphine dosing does not benefit treatment engagement and adherence during the post-detoxification period - A pilot randomized controlled trial},
journal = {Drug and Alcohol Dependence Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2772724626000806?dgcid=rss_sd_all}
}
Publication date: December 2026 Source: Journal of Electromyography and Kinesiology, Volume 91 Author(s): Mihailo Petrovic, Ann-Katrin Stensdotter, Helena Grip
Publication date: December 2026 Source: Journal of Electromyography and Kinesiology, Volume 91 Author(s): Michael Croskery, Victor Chan, Ryan B. Graham